News

Retatrutide: The Upcoming Triple-Agonist Weight Loss Drug Explained

Retatrutide is emerging as a next-generation weight loss medication with the potential to outperform current GLP-1 therapies. This guide explains how its triple-agonist mechanism works, what clinical trials reveal, and when NYC patients might expect access. Learn why safety, timing, and medical oversight matter as excitement builds around this new drug.

Continue reading